Brief: China SXT Pharmaceuticals Inc Obtained New Pharmaceutical Manufacturing Permit And Passed Its GMP Compliance-Inspection
18/10/2021 13:47
Oct 18 (Reuters) - China SXT Pharmaceuticals Inc SXTC.O :
* CHINA SXT PHARMACEUTICALS, INC. OBTAINED A NEW
PHARMACEUTICAL
MANUFACTURING PERMIT AND PASSED ITS GMP COMPLIANCE-INSPECTION
* CHINA SXT PHARMACEUTICALS INC - PASSED ITS PHARMACEUTICAL
GMP
COMPLIANCE-INSPECTION CONDUCTED BY JSMPA FOR NEW LYOPHILIZATION
PRODUCTION FACILITY
Source text for Eikon: ID:nPn27D5GCa
Further company coverage: SXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China SXT Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Univest Securities, Llc Announces Closing Of $9 Million Registered Direct Offering For Its Client China Sxt Pharmaceuticals Inc. (Nasdaq Sxtc)